AI-designed drug rentosertib slowed 6 of 6 proteomic aging clocks in trial
EricTopol · x · 2026-09-07
Insilico Medicine reports that rentosertib, a drug candidate designed with generative AI to treat chronic lung disease, may also slow aging.
- Results published in Nature Biotechnology, covered by NYT's Cade Metz
- In a small trial, the drug reduced proteomic aging clocks in 6 of 6 measures
- Researchers say the methods will be used in future trials; Eric Topol notes larger independent studies are needed
A milestone for AI drug discovery: one molecule targeting both a specific disease and the biology of aging.
Related event: AI-Designed Drug Reverses Six Aging Biomarkers in Trial(2 posts)→
More from Apps
- Blogger claims Claude has hidden Travel Planner Mode, shares 10 prompts to unlock it — hey_abusiddik · 2026-09-07
- AI Movie Studio 2 adds LoRA everywhere, experimental Long Take mode, and Docker support — purecharisma2020 · 2026-09-07
- RPCS3 emulator now plays PS3 discs directly from your PC disc drive, plug and play — mohbibi_ · 2026-09-07
- Mac users are using iPhone Mirroring (56MB) to free up RAM for local LLMs — bradnickel · 2026-09-07
- OpenMAIC, an open-source AI classroom, hits 20K GitHub stars — Shruti_0810 · 2026-09-07
- Dev builds what may be the first parkour game on Spawn with GPT-6, live now — majidmanzarpour · 2026-09-07